Items where authors include "McInnes, IB"

Article

McGonagle, D, McInnes, IB, Deodhar, A et al. (10 more authors) (2023) Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. ACR Open Rheumatology, 5 (4). pp. 227-240. ISSN 2578-5745

Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2022) Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD Open, 8 (2). e002518. ISSN 2056-5933

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Alunno, A, Najm, A, Machado, PM et al. (21 more authors) (2021) 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases. ISSN 0003-4967

Pratt, AG, Siebert, S, Cole, M et al. (13 more authors) (2021) Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. The Lancet Rheumatology, 3 (5). e337-e346. ISSN 2665-9913

Siebert, S, Pratt, AG, Stocken, DD orcid.org/0000-0001-8031-1738 et al. (9 more authors) (2020) Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial. Medicine, 99 (26). e20458. ISSN 0025-7974

Pitaksalee, R orcid.org/0000-0002-6488-2108, Burska, AN orcid.org/0000-0003-3321-9087, Ajaib, S et al. (11 more authors) (2020) Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients. Clinical Epigenetics, 12. 54. ISSN 1868-7075

McInnes, IB, Mease, PJ, Kivitz, AJ et al. (9 more authors) (2020) Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study. The Lancet Rheumatology, 2 (4). e227-e235. ISSN 2665-9913

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Coates, LC orcid.org/0000-0002-4756-663X, Wallman, JK, McGonagle, D et al. (9 more authors) (2019) Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies. Arthritis Research & Therapy, 21 (1). 266. ISSN 1478-6354

McGonagle, DG, McInnes, IB, Kirkham, BW et al. (2 more authors) (2019) The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: Recent advances and controversies. Annals of the Rheumatic Diseases, 78 (9). pp. 1167-1178. ISSN 0003-4967

Al-Laith, M, Jasenecova, M, Abraham, S et al. (27 more authors) (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials, 20 (1). 429. p. 429. ISSN 1745-6215

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis. Arthritis & Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis. Arthritis and Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Just, SA, Humby, F, Lindegaard, H et al. (18 more authors) (2018) Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe. RMD Open, 4 (2). e000799. ISSN 2056-5933

Tom, BDM, Symmons, D, Brockbank, S et al. (145 more authors) (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD OPEN, 4 (2). e000721. ISSN 2056-5933

Clunie, G, McInnes, IB, Barkham, N et al. (10 more authors) (2018) Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: A multicentre retrospective study. Rheumatology Advances in Practice, 2 (2). rky042. pp. 1-11. ISSN 2514-1775

Taylor, JC orcid.org/0000-0002-2518-5799, Bongartz, T, Massey, J et al. (37 more authors) (2018) Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients. The Pharmacogenomics Journal, 18 (4). pp. 528-538. ISSN 1470-269X

Taylor, PC, Kremer, JM, Emery, P et al. (14 more authors) (2018) Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies. Annals of the Rheumatic Diseases, 77 (7). pp. 988-995. ISSN 0003-4967

Veale, DJ, McGonagle, D, McInnes, IB et al. (8 more authors) (2018) The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis. Rheumatology. key070. ISSN 1462-0324

Smolen, JS, Aletaha, D, Barton, A et al. (8 more authors) (2018) Rheumatoid arthritis. Nature Reviews Disease Primers, 4. 18001.

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. Nature Reviews Rheumatology, 14 (2). p. 119. ISSN 1759-4790

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) The RA-MAP Consortium: A working model for academia-industry collaboration. Nature Reviews Rheumatology, 14 (1). pp. 53-60. ISSN 1759-4790

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Orr, C, Vieira-Sousa, E, Boyle, DL et al. (26 more authors) (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology, 13 (8). pp. 463-475. ISSN 1759-4790

Van der Heijde, D, Landewé, RB, Mease, PJ et al. (6 more authors) (2016) Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis. Arthritis & Rheumatology, 68 (8). pp. 1914-1921. ISSN 2326-5191

Dale, J, Stirling, A, Zhang, R et al. (8 more authors) (2016) Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Annals of the Rheumatic Diseases, 75 (6). pp. 1043-1050. ISSN 0003-4967

Gossec, L, Smolen, JS, Ramiro, S et al. (31 more authors) (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75 (3). pp. 499-510. ISSN 0003-4967

Baraliakos, X, Borah, B, Braun, J et al. (13 more authors) (2016) Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: An observational study. Annals of the Rheumatic Diseases, 75 (2). pp. 408-412. ISSN 0003-4967

Gossec, L, Smolen, JS, Gaujoux-Viala, C et al. (32 more authors) (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1). pp. 4-12. ISSN 0003-4967